Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jon Jackson

Psychiatry Jackson, MS Medical Doctor

NPI 1760669345 CMS profile 698644

2500 North State Street, Jackson, MS 39216

Open in the dashboard

General payments

$833,744

1,181 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jon Jackson of Jackson, MS is reported in the CMS Open Payments database as having received $833,744 across 1,181 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $206,057 230
2024 General $187,053 244
2023 General $148,446 200
2022 General $66,405 119
2021 General $57,087 116
2020 General $62,939 73
2019 General $105,757 199

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jon Jackson
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Jon Jackson were reported at $206,057. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Jon Jackson Psychiatry median Middle half National median
2019 $105,757 $184 $59–$605 $163
2020 $62,939 $119 $36–$372 $114
2021 $57,087 $143 $43–$576 $132
2022 $66,405 $153 $50–$590 $149
2023 $148,446 $170 $56–$651 $160
2024 $187,053 $179 $57–$673 $164
2025 $206,057 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alkermes, Inc. $636,477 860 payments
  2. Teva Pharmaceuticals USA, Inc. $193,790 205 payments
  3. Neurocrine Biosciences, Inc. $693 29 payments
  4. ITI, Inc. $602 7 payments
  5. Janssen Pharmaceuticals, Inc $389 13 payments
  6. Lundbeck LLC $327 15 payments
  7. Otsuka America Pharmaceutical, Inc. $248 11 payments
  8. E.R. Squibb & Sons, L.L.C. $222 7 payments
  9. Vanda Pharmaceuticals Inc. $203 6 payments
  10. Allergan Inc. $152 3 payments
  11. Other $641 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $706,297 266 payments
  2. Travel and Lodging $89,351 454 payments
  3. Food and Beverage $23,286 456 payments
  4. Consulting Fee $14,810 5 payments
Products named General payments · program years 2019–2025
  1. ARISTADA Cns $366,739 523 payments
  2. ARISTADA Cns $366,739 523 payments
  3. ARISTADA Cns $366,443 508 payments
  4. ARISTADA Cns $366,443 508 payments
  5. ARISTADA INITIO $346,334 486 payments
  6. LYBALVI Cns $290,426 388 payments
  7. LYBALVI Cns $270,021 351 payments
  8. LYBALVI Cns $269,739 337 payments
  9. LYBALVI Cns $269,739 337 payments
  10. UZEDY $193,576 195 payments
  11. Other $3,982 136 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,181 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record